Prolactin (PRL) has been reported to have many biological actions. However, recent studies indicate that PRL really is a family of hormones, each PRL variant having different biological activities.
The aim of the studies proposed in this application is to re-evaluate the role of PRL in various physiological processes based on the relative amounts of the PRL variants present. Since recent work has shown that the glycosylation of PRL alters its biological activity, determination of the factors that affect synthesis and secretion of the glycosylated form may provide insight into the physiological role of glycosylated PRL. The studies proposed will focus on the differences in the secretory patterns of the glycosylated form of human PRL (G-hPRL) in comparison to those of the nonglycosylated form of human PRL (hPRL).
The specific aims are: 1) To measure G-hPRL and hPRL in normal women, hormoprolactinemic women with galactorrhea and amenorrhea, and hyperprolactinemic women. 2) To use primary cultures of human pituitary cells as a model system to investigate the effects of various secretagogues on the in vitro synthesis and release of G-hPRL and hPRL. 3) To develop monoclonal antibodies that will be specific for G-hPRL or hPRL and to use these monoclonal antibodies to develop specific immunoassays. 4) To study individual pituitary cells in vitro to determine if they contain and are capable of secreting both G-hPRL and hPRL. The hypothesis to be tested is that a specific PRL variant performs a specific physiological function. This hypothesis implies that this difference in function will be reflected in the differential secretion patterns of G-hPRL and hPRL.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Reproductive Endocrinology Study Section (REN)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Markoff, E; Henemyre, C; Fellows, J et al. (1995) Localization of insulin-like growth factor binding protein-4 expression in the mouse uterus during the peri-implantation period. Biol Reprod 53:1103-9
Heffner, L J; Markoff, E; Yuan, R W et al. (1995) Glycosylated human prolactin: detection by immunoblotting of biological fluids is confounded by antisera crossreactivity with immunoglobulins. Biochem Biophys Res Commun 212:48-55
Carlson, H E; Markoff, E; Lee, D W (1992) On the nature of serum prolactin in two patients with macroprolactinemia. Fertil Steril 58:78-87
Haro, L S; Lee, D W; Singh, R N et al. (1990) Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay. J Clin Endocrinol Metab 71:379-83
Liu, J H; Lee, D W; Markoff, E (1990) Differential release of prolactin variants in postpartum and early follicular phase women. J Clin Endocrinol Metab 71:605-10
McCoshen, J; Patalas, E; Markoff, E et al. (1990) Comparisons of glycosylated and nonglycosylated amniotic fluid prolactins in normal second- and third-trimester pregnancies. Am J Obstet Gynecol 163:81-5
Markoff, E; Beattie, G M; Hayek, A et al. (1990) Effects of prolactin and glycosylated prolactin on (pro)insulin synthesis and insulin release from cultured rat pancreatic islets. Pancreas 5:99-103
Markoff, E; Sigel, M B; Lacour, N et al. (1988) Glycosylation selectively alters the biological activity of prolactin. Endocrinology 123:1303-6
Markoff, E; Lee, D W; Hollingsworth, D R (1988) Glycosylated and nonglycosylated prolactin in serum during pregnancy. J Clin Endocrinol Metab 67:519-23
Markoff, E; Lee, D W (1987) Glycosylated prolactin is a major circulating variant in human serum. J Clin Endocrinol Metab 65:1102-6